Covenant Partners, LLC Dexcom Inc Transaction History

Covenant Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$112.47 - $130.98 $12,146 - $14,145	108 Added 2.58%	4,290 $551,000
Q1 2023 Apr 19, 2023	BUY	$104.0 - $122.92 $9,568 - $11,308	92 Added 2.25%	4,182 $485,000
Q4 2022 Feb 17, 2023	BUY	$84.98 - $122.67 $21,839 - $31,526	257 Added 6.7%	4,090 $463,000
Q3 2022 Nov 10, 2022	BUY	$76.35 - $94.18 $292,649 - $360,991	3,833 New	3,833 $309,000
Q2 2022 Jul 27, 2022	SELL	$67.99 - $132.89 $54,731 - $106,976	-805 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$94.08 - $130.2 $3,198 - $4,426	-34 Reduced 4.05%	805 $412,000
Q2 2021 Aug 02, 2021	BUY	$80.99 - $107.93 $67,950 - $90,553	839 New	839 $358,000

1,084

352M

8.45M

5.75M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $33.2B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Covenant Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Covenant Partners, LLC with notifications on news.